Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal health agent for preventing and treating canine urinary calculi

A technology of urinary calculus and health care agent, which is applied in the field of medicinal health care agents for the prevention and treatment of canine urolithiasis, which can solve the problems of high price and difficulty of pushing away, and achieve the effects of reducing the chance of formation, inhibiting the crystallization process, and promoting combination

Inactive Publication Date: 2010-03-10
TIANJIN SHENGJI GRP CO LTD
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Now the Hill Company of the United States has developed a series of prescription diets for the prevention and treatment of dog stones, but the price is relatively high, and it is difficult to widely promote them in the market.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal health agent for preventing and treating canine urinary calculi
  • Medicinal health agent for preventing and treating canine urinary calculi
  • Medicinal health agent for preventing and treating canine urinary calculi

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] A medicinal health care agent for preventing and treating canine urolithiasis, which is characterized in that it is formed by uniformly mixing the following active ingredients according to weight or unit ratio: organic germanium 10mg, potassium citrate 1000mg, desmodium granules 20000mg, vitamin A 5000IU, vitamin B6 10mg.

[0013] Among the present invention, the steps of the desmodium granules are as follows:

[0014] Take Desmodium syringae and decoct in water three times, filter them separately and combine the filtrates, heat and concentrate the filtrates and then conventionally granulate, each gram of granules contains 1g of crude drug.

Embodiment 2

[0016] A medicinal health care agent for preventing and treating canine urolithiasis, which is characterized in that it is formed by uniformly mixing the following active ingredients according to weight or unit ratio: organic germanium 20mg, potassium citrate 1000mg, desmodium granules 20000mg, vitamin A 5000IU, vitamin B610mg . Others are with embodiment 1.

Embodiment 3

[0018] A medicinal health care agent for preventing and treating canine urolithiasis, which is characterized in that it is formed by uniformly mixing the following active ingredients according to weight or unit ratio: organic germanium 20mg, potassium citrate 3000mg, desmodium granules 20000mg, vitamin A5000IU, vitamin B6 10mg . Others are with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicinal health agent for preventing and treating canine urinary calculi, which is characterized in that the agent is obtained by evenly mixing the following effective components in ratio by weight or unit: 10 to 40 mg of organic germanium, 1,000 to 6,000 mg of potassium citrate, 20,000 mg of lysimachia nummularia particles, 5,000 IU of vitamin A and 10 mg of vitamin B6, wherein the vitamin A maintains the integrity of urinary tract epithelium to realize the activity of crystallization inhibitor so as to inhibit crystallization; the organic germanium enhances the process of crystallization inhibition; lysimachia nummularia promotes urination, treats stranguria and plays a significant role in promoting urination and removing stones; meanwhile, the lysimachia nummularia has the function of resisting inflammation and bacteria, reduces urinary tract injury, inhibits urease-producing bacteria, and turns urine to be acidic after the lysimachia nummularia is metabolized in human bodies so as to inhibit the formation of magnesium ammonium phosphate stones; citric acid competes with oxalic acid for calcium in urine; and the vitamin B6 promotes the combination ofthe citric acid with urine calcium so as to reduce the chance of forming calcium oxalate stones. The health agent is reasonable in compatibility, and jointly uses medicaments from different angles toeliminate the inducing factors of magnesium ammonium phosphate and calcium oxalate urinary calculi which are the most common among dogs.

Description

technical field [0001] The invention relates to a medicinal health-care agent for dogs, in particular to a medicinal health-care agent added to feed for preventing and treating canine urolithiasis. Background technique [0002] In recent years, pet dogs have become people's favorite companion animals, and working dogs have played an irreplaceable role in military and police anti-drug inspections. Meat dog breeding has even driven the development of the entire dog industry. In the feeding and management of dogs, disease is the most important link affecting the health of dogs, especially under the feeding of high nutritional level, urinary calculus has become one of the most common diseases in veterinary clinics. According to domestic and foreign research data statistics, its clinical incidence rate is 0.5-1.0%. Due to the complex pathogenic factors of stones, the recurrence rate of urolithiasis can be as high as 50% within two years after treatment. It is of great significan...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/53A61P13/04A61K31/07A61K31/194A61K31/4415
Inventor 王金勇王连民
Owner TIANJIN SHENGJI GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products